| |
| |
|
| Insider
Information: |
Clackson Timothy P |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
737,796 |
|
|
Indirect Shares
|
118,218 |
|
|
| Direct
Value |
$359,460 |
|
|
|
Indirect Value
|
$181,747 |
|
|
| Total
Shares |
856,014 |
|
|
| Total
Value |
$541,208 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
President, R&D, CSO |
2016-03-22 |
316,212 |
2004-01-05 |
0 |
Premium* |
|
|
F-star Therapeutics, Inc |
FSTX |
Director |
2020-09-30 |
50,486 |
2018-07-02 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
2022-10-14 |
0 |
|
0 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
President and CEO, Dir... |
2022-11-11 |
351,030 |
|
0 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
10% Owner |
2021-10-21 |
20,068 |
2021-10-21 |
70,888 |
Premium* |
|
|
Elevation Oncology, Inc. |
ELEV |
|
2023-09-01 |
0 |
2023-09-01 |
47,330 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,820 |
D/D |
(14,667) |
428,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-02-20 |
4 |
AS |
$8.00 |
$392,280 |
D/D |
(49,035) |
428,232 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-03-19 |
4 |
AS |
$9.00 |
$185,913 |
D/D |
(20,657) |
440,314 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-03-20 |
4 |
AS |
$8.84 |
$47,910 |
D/D |
(5,417) |
433,648 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$57,016 |
D/D |
(6,667) |
440,314 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-04-23 |
4 |
AS |
$9.50 |
$1,175,777 |
D/D |
(123,766) |
316,548 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$59,797 |
D/D |
(7,000) |
325,336 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$56,560 |
D/D |
(8,750) |
334,086 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$70,517 |
D/D |
(14,667) |
350,052 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2016-03-02 |
4 |
AS |
$6.00 |
$150,282 |
D/D |
(25,047) |
344,255 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,867 |
D/D |
(9,625) |
334,630 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• – – |
2016-03-19 |
4 |
AS |
$6.47 |
$35,039 |
D/D |
(5,417) |
340,046 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• – – |
2016-03-22 |
4 |
AS |
$6.58 |
$156,871 |
D/D |
(23,834) |
316,212 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Pres., R & D., Chief Sci. Off. |
• – – |
2010-10-26 |
4 |
B |
$3.70 |
$37,000 |
D/D |
10,000 |
117,437 |
2.74 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-23 |
4 |
B |
$0.00 |
$0 |
D/D |
23,590 |
23,590 |
2.31 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
President and CEO |
• • – |
2021-12-21 |
4 |
B |
$9.76 |
$25,381 |
D/D |
2,600 |
348,530 |
2.81 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
President and CEO |
• • – |
2022-11-11 |
4 |
B |
$6.80 |
$16,995 |
D/D |
2,500 |
351,030 |
2.81 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• – – |
2011-03-22 |
4 |
D |
$6.39 |
$78,424 |
D/D |
(12,273) |
141,373 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• – – |
2011-04-11 |
4 |
D |
$7.76 |
$103,123 |
D/D |
(13,289) |
180,084 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• – – |
2011-06-07 |
4 |
D |
$8.65 |
$378,576 |
D/D |
(43,766) |
196,318 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$164,306 |
D/D |
(8,142) |
255,940 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$28,190 |
D/D |
(3,442) |
387,711 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
President, R&D, CSO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$25,421 |
D/D |
(4,564) |
413,565 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,840) |
0 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
Director |
– • – |
2022-05-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
31,553 |
15,777 |
0 |
- |
|
94 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
